Standardizing Safe Cefazolin Use in Total Joint Arthroplasty: A Multidisciplinary Triage Protocol
The Journal of Arthroplasty · 2026
DOI: 10.1016/j.arth.2026.03.100 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift The Journal of Arthroplasty, 2026. Verfasst von John M Guido und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, West Virginia University, Morgantown, West Virginia. Hauptthemen laut MEDLINE: Cefazolin, Anti-Bacterial Agents, Drug Hypersensitivity, Prosthesis-Related Infections. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cefazolin is the first-line perioperative antimicrobial for total joint arthroplasty (TJA) due to its efficacy against typical skin pathogens, favorable safety profile, and cost-effectiveness. Its use reduces the risk of periprosthetic joint infection (PJI) by over 30% compared to second-line antimicrobials. Approximately 15% of patients report a penicillin allergy, although true allergy is confirmed in only 1 to 10% of these cases. Cefazolin's unique molecular structure of the R1 side chain prevents immediate immunoglobulin E (IgE)-mediated cross-reactivity with penicillin or other cephalosporins. Severe cutaneous adverse reactions or delayed hypersensitivity reactions to beta-lactam antimicrobials are rare, less understood, and involve T-cell-mediated pathways. Despite evidence suggesting no immediate IgE-mediated cross-reactivity risk, it is still common practice to use second-line antimicrobials or preoperative allergy testing in patients with a reported penicillin allergy or cephalosporin allergy. METHODS: In January 2025, a multidisciplinary team implemented a novel algorithmic triage protocol for patients with penicillin allergy and cephalosporin allergy undergoing TJA. Patients who had a history of cefazolin allergy, anaphylaxis, or angioedema to any cephalosporin or severe cutaneous adverse reactions/delayed hypersensitivity reactions to any beta-lactam were referred for preoperative allergy testing. Patients who had an IgE-mediated reaction to penicillin (including anaphylaxis and angioedema) or a nonanaphylactic reaction to a noncefazolin cephalosporin were considered at no increased risk and received cefazolin without additional testing. RESULTS: In 2024, 62 patients were referred for allergy testing, with only six being recommended to avoid cefazolin. Since the implementation of the new protocol in January 2025, no patients have been referred for beta-lactam allergies, and there have been no perioperative hypersensitivity reactions. CONCLUSIONS: This standardized, multidisciplinary approach promotes safe cefazolin administration in patients who have listed penicillin allergy or cephalosporin allergy, thereby optimizing outcomes, reducing unnecessary health care utilization, and improving care across perioperative settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, West Virginia University, Morgantown, West Virginia.
- Division of Infectious Diseases, Department of Medicine, West Virginia University, Morgantown, West Virginia.
- Department of Pharmacy Services, West Virginia University Medicine - WVU Hospitals, Morgantown, West Virginia.
- Division of Pediatric & Adult Allergy/Immunology, Department of Pediatrics, West Virginia University, Morgantown, West Virginia.
Zitieren
APA
Guido, J. M., Hudock, N. L., Frye, B. M., Parrish, K. L., Lastinger, A. M., Howard, C. A., Matyus, V. L., Leadman, K. M., Pincavitch, J. D., & Peppers, B. P. (2026). Standardizing Safe Cefazolin Use in Total Joint Arthroplasty: A Multidisciplinary Triage Protocol. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2026.03.100
Vancouver
Guido JM, Hudock NL, Frye BM, Parrish KL, Lastinger AM, Howard CA, et al. Standardizing Safe Cefazolin Use in Total Joint Arthroplasty: A Multidisciplinary Triage Protocol. The Journal of Arthroplasty. 2026. doi:10.1016/j.arth.2026.03.100
BibTeX
@article{Guido2026,
author = {Guido, John M and Hudock, Nicholas L and Frye, Benjamin M and Parrish, Kylie L and Lastinger, Allison M and Howard, Catessa A and Matyus, Valerie L and Leadman, Kelsey M and Pincavitch, Jami D and Peppers, Brian P},
title = {Standardizing Safe Cefazolin Use in Total Joint Arthroplasty: A Multidisciplinary Triage Protocol},
journal = {The Journal of Arthroplasty},
year = {2026},
doi = {10.1016/j.arth.2026.03.100}
}
EUVIMED